Literature DB >> 33078601

Comments on: Fertility-sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: a Gynecologic Cancer Inter-Group (GCIG) study.

Jeong Yeol Park1.   

Abstract

Entities:  

Year:  2020        PMID： 33078601      PMCID： PMC7593221          DOI： 10.3802/jgo.2020.31.e96

Source DB:  PubMed          Journal:  J Gynecol Oncol        ISSN： 2005-0380            Impact factor:   4.401


× No keyword cloud information.
  9 in total

Review 1.  Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature.

Authors:  J Baker; A Obermair; V Gebski; M Janda
Journal:  Gynecol Oncol       Date:  2011-12-03       Impact factor: 5.482

Review 2.  Levonorgestrel-Releasing Intrauterine Systems Versus Oral Cyclic Medroxyprogesterone Acetate in Endometrial Hyperplasia Therapy: A Meta-Analysis.

Authors:  Jin-Sung Yuk; Jae Yen Song; Jung Hun Lee; Won I Park; Hyeong Sik Ahn; Hyun Jung Kim
Journal:  Ann Surg Oncol       Date:  2016-11-28       Impact factor: 5.344

3.  Hormonal therapy for women with stage IA endometrial cancer of all grades.

Authors:  Jeong-Yeol Park; Dae-Yeon Kim; Tae-Jin Kim; Jae Weon Kim; Jong-Hyeok Kim; Yong-Man Kim; Young-Tak Kim; Duk-Soo Bae; Joo-Hyun Nam
Journal:  Obstet Gynecol       Date:  2013-07       Impact factor: 7.661

4.  The Value of Preoperative Positron Emission Tomography/Computed Tomography in Node-Negative Endometrial Cancer on Magnetic Resonance Imaging.

Authors:  Jeong-Yeol Park; Jong Jin Lee; Hyuck Jae Choi; In Hye Song; Chang Ohk Sung; Hye Ok Kim; Sun-Young Chae; Young-Tak Kim; Joo-Hyun Nam
Journal:  Ann Surg Oncol       Date:  2017-05-26       Impact factor: 5.344

5.  Usefulness of sentinel lymph node mapping using indocyanine green and fluorescent imaging in the diagnosis of lymph node metastasis in endometrial cancer.

Authors:  Geon-Woo Lee; Jeong-Yeol Park; Dae-Yeon Kim; Dae-Shik Suh; Jong-Hyeok Kim; Yong-Man Kim; Young-Tak Kim; Joo-Hyun Nam
Journal:  J Obstet Gynaecol       Date:  2020-08-20       Impact factor: 1.246

6.  Dual progestin therapy for fertility-sparing treatment of grade 2 endometrial adenocarcinoma.

Authors:  A M Newtson; J B Pakish; A M Nick; S N Westin
Journal:  Gynecol Oncol Rep       Date:  2017-08-08

7.  Fertility-sparing treatment in early endometrial cancer: current state and future strategies.

Authors:  Andreas Obermair; Eva Baxter; Donal J Brennan; Jessica N McAlpine; Jennifer J Muellerer; Frédéric Amant; Mignon D J M van Gent; Robert L Coleman; Shannon N Westin; Melinda S Yates; Camilla Krakstad; Monika Janda
Journal:  Obstet Gynecol Sci       Date:  2020-07-08

8.  Medroxyprogesterone acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma: trial protocol for a prospective, randomised, open, blinded-endpoint design, dose-response trial (FELICIA trial).

Authors:  Akira Mitsuhashi; Yohei Kawasaki; Makoto Hori; Tadami Fujiwara; Hideki Hanaoka; Makio Shozu
Journal:  BMJ Open       Date:  2020-02-28       Impact factor: 2.692

9.  Fertility-sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: a Gynecologic Cancer Inter-Group (GCIG) study.

Authors:  Francesca Falcone; Umberto Leone Roberti Maggiore; Violante Di Donato; Anna Myriam Perrone; Luigi Frigerio; Giuseppe Bifulco; Stephan Polterauer; Paolo Casadio; Gennaro Cormio; Valeria Masciullo; Mario Malzoni; Stefano Greggi
Journal:  J Gynecol Oncol       Date:  2020-09       Impact factor: 4.401
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.